AstraZeneca 2Q Rev. $6.45B; Est. $6.33B

July 31 (Bloomberg) –- Bloomberg’s Caroline Hyde reports earnings for AstraZeneca, Britain’s second-biggest drug maker, which raised its full-year forecast. She speaks to Mark Barton and Ryan Chilcote on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

Kimmitt Says North Korea Military Option on the Table
31:30 - Former U.S. Ambassador to Germany Robert Kimmitt discusses U.S.-North Korea tensions and President Trump’s first hundred days. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Rep. Kilmer Says Tax Code Doesn’t Encourage Investment
  • Markets React to Barclays Earnings
  • Richard Haass Says China Wants a Divided Korea